UY27408A1 - Pramipexol para el tratamiento del adhd. - Google Patents

Pramipexol para el tratamiento del adhd.

Info

Publication number
UY27408A1
UY27408A1 UY27408A UY27408A UY27408A1 UY 27408 A1 UY27408 A1 UY 27408A1 UY 27408 A UY27408 A UY 27408A UY 27408 A UY27408 A UY 27408A UY 27408 A1 UY27408 A1 UY 27408A1
Authority
UY
Uruguay
Prior art keywords
adhd
treatment
pramipexol
propylamino
benzothiazole
Prior art date
Application number
UY27408A
Other languages
English (en)
Spanish (es)
Inventor
Jurgen Reess
Dr Franco Borsini
Original Assignee
Boehringer Ingelheim Pharma
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma, Co Kg filed Critical Boehringer Ingelheim Pharma
Publication of UY27408A1 publication Critical patent/UY27408A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UY27408A 2001-08-03 2002-08-02 Pramipexol para el tratamiento del adhd. UY27408A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10137633A DE10137633A1 (de) 2001-08-03 2001-08-03 Pramipexol zur Behandlung von ADHD

Publications (1)

Publication Number Publication Date
UY27408A1 true UY27408A1 (es) 2003-02-28

Family

ID=7693957

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27408A UY27408A1 (es) 2001-08-03 2002-08-02 Pramipexol para el tratamiento del adhd.

Country Status (8)

Country Link
EP (1) EP1416930A1 (https=)
JP (1) JP2005500368A (https=)
AR (1) AR035273A1 (https=)
CA (1) CA2453485A1 (https=)
DE (1) DE10137633A1 (https=)
MX (1) MXPA04001001A (https=)
UY (1) UY27408A1 (https=)
WO (1) WO2003013520A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200906997A1 (tr) 2009-09-11 2011-03-21 Sanovel �La� San. Ve T�C. A. �. Pramipeksol farmasötik bileşimleri.
TR200907554A1 (tr) * 2009-10-06 2011-04-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Oral yolla dağılan pramıpexole bileşimleri.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5621133A (en) * 1989-05-31 1997-04-15 Deninno; Michael P. Dopamine agonists
US7049337B2 (en) * 2000-05-19 2006-05-23 Wayne State University Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential CNS receptor activity and behavior
US20020016334A1 (en) * 2000-07-31 2002-02-07 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
US6613308B2 (en) * 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system

Also Published As

Publication number Publication date
AR035273A1 (es) 2004-05-05
DE10137633A1 (de) 2003-02-20
EP1416930A1 (de) 2004-05-12
CA2453485A1 (en) 2003-02-20
JP2005500368A (ja) 2005-01-06
MXPA04001001A (es) 2004-04-20
WO2003013520A1 (de) 2003-02-20

Similar Documents

Publication Publication Date Title
CR7261A (es) Derivados de diarilcicloalquilo, procedimiento para su preparacion y su utilizacion como agentes activadores del ppar
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
UY29927A1 (es) Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
UY30025A1 (es) Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones.
ECSP055747A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
AR002043A1 (es) Utilizacion de agonistas de alfa (1l) para el tratamiento de la incontinencia urinaria.
ECSP088593A (es) 5-(arilsulfonil)-pirazolopiperidinas
PY0219683A (es) Compuestos biciclicos aromaticos sustituidos con amino-alquilo, procedimiento para su preparacion y su utilizacion como medicamentos
ZA200604114B (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
SV1999000047A (es) Nuevas dihidropirimidinas fef. lea 32792-sv
PA8543201A1 (es) DERIVADOS DE DIHIDRO-BENZO [B] [1,4]-DIAZEPIN-2-ONA COMO ANTAGONISTAS I DE mGluR2
ECSP045156A (es) Derivados de indolilalquilamina como ligandos 5-hidroxitriptamina-6
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización
ES2193065T3 (es) Nueva utilizacion del saredutant.
UY27408A1 (es) Pramipexol para el tratamiento del adhd.
AR055011A1 (es) Compuesto de tetrahidroquinolina, proceso de preparacion del compuesto y su uso para la preparacion de un farmaco
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
AU2002365288A1 (en) Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
BR0104005A (pt) Composição farmacêutica para a prevenção ou para o tratamento de uma doença associada com um excesso de produção de il-2
ATE520657T1 (de) Lisofyllin-analogika und ihre pharmazeutischen verwendungen
MXPA04000918A (es) Pramipexol como anticonvulsivo.
ITRM20050521A1 (it) Composizione a base di vitamine k e d per la prevenzione e il trattamento dell'osteoporosi.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141226